As Avastin needs to be removed from its original vials and introduced into single-use syringes suitable for injection into the eye, Novartis and Roche have long argued that the repackaging ...

Genentech opposes the use of Avastin to treat eye diseases such as macular degeneration, noting that the drug isn't approved by regulators for this purpose. Genentech has a similar drug ...

The UK’s Court of Appeal has upheld a lower court’s ruling that the cancer drug Avastin (bevacizumab) can be used off-label to treat the eye disease wet age-related macular degeneration (wet ...